Vimentin and Cytokeratin Immunostaining: The Role in Basic Diagnosis and Prognosis of Sarcomas

  • Samuel Ifedioranma Ogenyi Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nigeria
  • Jonathan Madukwe Department of Histopathology, National Hospital, Abuja, Nigeria
  • Anulika Obianuju Onyemelukwe Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Nigeria
  • Anthony Ajuluchukwu Ngokere Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nigeria

Abstract

Introduction: Specific diagnosis which provides diagnostic, prognostic, and therapeutic information to guide patient care defines the primary goal of sarcoma management and care. The role of immunohistochemistry, using vimentin (mesenchymal linage marker) and cytokeratin (epithelial linage marker) as basic markers for diagnosis and classification of sarcomas for specific management strategies and prognosis was elucidated in the present study.


Materials and Methods: Twenty four (24) archived paraffin wax processed tissue block sarcoma samples were randomly selected from the histopathology Laboratories and museums of the Nnamdi Azikiwe University Teaching Hospital (NAUTH) Nnewi and National hospital Abuja and necessary data obtained from records. Blocks were re-embedded with fresh paraffin wax and 3µ thick sections cut with the aid of a rotary microtome. Haematoxylin and Eosin staining method was employed to confirm diagnosis before proceeding to immunohistochemistry. Antibodies for vimentin and pancytokeratin were employed for immunohistochemistry while exposed mouse and rabbit specific horseradish peroxides/diaminobenzidine detection IHC kit was employed for immunostaining.


Results: The mean age of patients was 26 years while the ages range from 11 to 48 years with 14 (58.3%) females and 10 (41.7%) males. Vimentin had strong positive immunoreactivity for all sarcoma samples whereas cytokeratin had positive immunoreactions for synovial sarcoma only, which also showed co-expression of both genes.


Conclusion: Vimentin and cytokeratin may play vital role as basic biomarkers not only for diagnosis and characterization of sarcomas but for specific management regime and prognostication. However, IHC must be performed at high standard using appropriate antibodies, samples and reagents.


Keywords: Sarcoma, immunohistochemistry, vimentin, cytokeratin, biomarker.

Keywords: Sarcoma, immunohistochemistry, vimentin, cytokeratin, biomarker

Downloads

Download data is not yet available.

Author Biographies

Samuel Ifedioranma Ogenyi, Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nigeria

Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nigeria

Jonathan Madukwe, Department of Histopathology, National Hospital, Abuja, Nigeria

Department of Histopathology, National Hospital, Abuja, Nigeria

Anulika Obianuju Onyemelukwe, Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Nigeria

Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Nigeria

Anthony Ajuluchukwu Ngokere, Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nigeria

Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nnewi Campus, Nigeria

References

1. Wei S, Henderson-Jackson E Qian X, Bui MM, “Soft Tissue Tumor Immunohistochemistry Update” Arch Pathol Lab Med, 2017; 141:1072–1091.
2. Soglia F, Mazzoni M, Zappaterra M, Di Nunzio M, Babini E, Bordini M, Sirri F, Clavenzani P, Davoli R, Petracci M, “Distribution and Expression of Vimentin and Desmin in Broiler Pectoralis major Affected by the Growth-Related Muscular Abnormalities” Front. Physiol, 2020; 10:1581.
3. Bashya R, Pathak TB, Shrestha S, Pun CB, Banstola S, Neupane S, Lee MC, “Role of immunohistochemistry in the diagnosis of malignant small round cell tumors” JPN, 2011; 1:87-91
4. Bahrami A, Truong LD, Jae Y. Ro JY, “Undifferentiated Tumor: True Identity by Immunohistochemistry” Arch Pathol Lab Med, 2008; 132:326–348
5. Parham DM, “Immunohistochemical Markers of Soft Tissue Tumors: Pathologic Diagnosis, Genetic Contributions, and Therapeutic Options” Anal. Chem. Insights, 2015; 10(S1):1–10.
6. Kristin B, Sean D, Cristina RA, Ursula LH, Robert LW, Yidong C, Arthur AG, Paul HD, Paul SM, “Gene Expression Profiling of Human Sarcomas: Insights into Sarcoma Biology” Cancer Res, 2005; 65(20)9226- 35.
7. Mandong BM, Kidmas AT, Manasseh AN, Echejoh GO, Tanko MN, Madaki AJ, “Epidemiology of soft tissue sarcomas in Jos, North Central Nigeria” Niger J Med. 2007; 16(3):246-9.
8. Dauda MA, Yakubu D, Mandong BM, Ojo EO, “Sarcomas in Nigerian Children in Jos North Central Nigeria” Afr J Med Med Sci, 2014; 43(Suppl 1):37–44.
9. Nishio J, Althof, PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ, Bridge JA, “Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma” Lab. Invest, 2006; 86:547–556.
10. Zlobec I, Steel R, Michel RP, Compton CC, Lugli A, Jass JR, “Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer” Mod Patholo, 2006; 19:1236–1242.
11. Ikeri NZ, Akinjo AO, Ajayi OO, Fehintola Banjo AA, Histological types of soft-tissue sarcomas at the Lagos university teaching hospital” Niger Postgrad Med J, 2017; 24:205-9.
12. Morgan R, Handbook of Small Animal Practice. 5th ed. Philadelphia: W.B. Saunders Ltd; 2008, P, 763-777
Statistics
27 Views | 16 Downloads
How to Cite
1.
Ogenyi SI, Madukwe J, Onyemelukwe AO, Ngokere AA. Vimentin and Cytokeratin Immunostaining: The Role in Basic Diagnosis and Prognosis of Sarcomas. JDDT [Internet]. 15May2020 [cited 1Jun.2020];10(3):175-8. Available from: http://jddtonline.info/index.php/jddt/article/view/4033